iShares U.S. Medical Devices ETF (IHI)

On our macro desk, we are closely tracking IHI's ongoing struggles as it sits down 20% this year. The persistent bearish trend and cyclical pressures are hard to ignore. While some desks are pitching it as a rotation candidate if the broader AI trade has peaked, we remain cautious due to the immediate overhang of pressured consumers and lack of clarity around upcoming healthcare policy.

Looking at the quantitative metrics on our screen, the short-term momentum for the iShares U.S. Medical Devices ETF has turned sluggish. Average weekly price growth across its constituent stocks is running at -1%, and the monthly figures mirror this downward trajectory. Anyone entering this exchange-traded fund right now needs to account for this weak technical price action before calling a definitive bottom.

From a strategic portfolio construction standpoint, evaluating IHI requires weighing its long-term sectoral design against current macroeconomic headwinds. Having tracked the fund since its launch back in May 2006, its indexing of U.S. medical device equities remains fundamentally sound, but the near-term risk-reward profile is clouded by consumer strain and policy uncertainty, requiring strict risk management protocols.